Compounds > 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine
Page last updated: 2024-09-05

4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine and Dyskinesia, Drug-Induced

4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine has been researched along with Dyskinesia, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cartwright, H; Castagnoli, N; Halliday, GM; McRitchie, DA; Pond, SM; Van der Schyf, CJ1
Eyles, DW; Halliday, GM; Pond, SM; Van der Schyf, CJ1

Other Studies

2 other study(ies) available for 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine and Dyskinesia, Drug-Induced

ArticleYear
Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
    Experimental neurology, 1999, Volume: 158, Issue:1

    Topics: Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Facial Muscles; Haloperidol; Hypothalamus; Male; Neurons; Papio; Prosencephalon

1999
Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia.
    Life sciences, 2000, Feb-25, Volume: 66, Issue:14

    Topics: Animals; Antipsychotic Agents; Basal Ganglia; Caudate Nucleus; Dyskinesia, Drug-Induced; Haloperidol; Male; Mitochondria; Neuroglia; Neurons; Neuropil; Papio; Putamen

2000